In the Netherlands, IFF announced the launch of its new-to-the-world Designed Enzymatic Biomaterials (DEB) technology for the development of biobased materials at scale. Designed to deliver meaningful sustainability benefits – with performance comparable or superior to fossil-based materials – DEB technology helps to address growing preferences for environmentally-friendly, high-performance biopolymers.
The technology platform offers manufacturers the opportunity to meet regulatory changes and mounting consumer demands to replace traditional fossil-based synthetic polymers. DEB is poised to lead the rapidly progressing bio-revolution by unlocking purposeful and sustainable innovation across various applications and products in home care, personal care, fabric care and industrial markets.
